BUY Timken India Ltd — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
Timken India reported standalone net profit of Rs 1,160.64 million for the quarter ended September 30, 2026, compared to Rs 894.66 million in the same quarter of the previous year.
NSE · Outcome of Board Meeting·29 Oct · 1w ago
Timken India reported standalone net profit of 1,160.64 million for the quarter ended September 30, 2026, compared to 894.66 million in the same quarter of the previous year.
BSE · Board Meeting·29 Oct · 1w ago
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·19 Jun · 5mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Timken India
- BUY — Om Mehra, SAMCO Securities24 Jul 2026 · ~2 weeks · target ₹3,580 · Expired
- BUY — Geojit Financial Services19 Jun 2026 · ~1 year · target ₹4,207 · Active
- BUY — Emkay Global19 Jun 2026 · ~1 year · target ₹4,207 · Active
- BUY — Foram Chheda21 May 2026 · ~2 weeks · target ₹3,770 · SL hit
- BUY — ICICI Securities20 May 2026 · ~1 year · target ₹4,600 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

